Trial Profile
Efficacy and safety of recombinant human thrombomodulin for the patients with coagulopathy before cardiovascular surgery
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 May 2013
Price :
$35
*
At a glance
- Drugs Thrombomodulin alfa (Primary)
- Indications Disseminated intravascular coagulation; Embolism and thrombosis
- Focus Therapeutic Use
- 06 May 2013 New trial record